HIST1H2BG |
HIST1H2BC, H2BFL, HIST1H2BE, H2BFH, HIST1H2BF, H2BFG, HIST1H2BG, H2BFA, HIST1H2B |
UBE2B |
UBE2B, RAD6B: Ubiquitin-conjugating enzyme E2 B |
1.225 |
Evidence |
|
KPNA5 |
KPNA5: Importin subunit alpha-6 |
DDX18 |
DDX18: ATP-dependent RNA helicase DDX18 |
1.225 |
Evidence |
|
RNF40 |
RNF40, BRE1B, KIAA0661: E3 ubiquitin-protein ligase BRE1B |
UBR2 |
UBR2, C6orf133, KIAA0349: E3 ubiquitin-protein ligase UBR2 |
1.225 |
Evidence |
|
RPS6KA5 |
RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5 |
PDLIM5 |
PDLIM5, ENH: PDZ and LIM domain protein 5 |
1.222 |
Evidence |
|
MSN |
MSN: Moesin |
PDLIM5 |
PDLIM5, ENH: PDZ and LIM domain protein 5 |
1.222 |
Evidence |
|
GABRB1 |
GABRB1: Gamma-aminobutyric acid receptor subunit beta-1 precursor |
GABRA2 |
GABRA2: Gamma-aminobutyric acid receptor subunit alpha-2 precursor |
1.222 |
Evidence |
|
GABRA5 |
GABRA5: Gamma-aminobutyric acid receptor subunit alpha-5 precursor |
GABRA2 |
GABRA2: Gamma-aminobutyric acid receptor subunit alpha-2 precursor |
1.222 |
Evidence |
|
GABRA5 |
GABRA5: Gamma-aminobutyric acid receptor subunit alpha-5 precursor |
GLRB |
GLRB: Glycine receptor subunit beta precursor |
1.222 |
Evidence |
|
ADCYAP1 |
ADCYAP1: Pituitary adenylate cyclase-activating polypeptide precursor |
SCTR |
SCTR: Secretin receptor precursor |
1.22 |
Evidence |
|
LPHN1 |
LPHN1, KIAA0821, LEC2: Latrophilin-1 precursor |
ADCYAP1 |
ADCYAP1: Pituitary adenylate cyclase-activating polypeptide precursor |
1.22 |
Evidence |
|
PROS1 |
PROS1, PROS: Vitamin K-dependent protein S precursor |
ITIH1 |
ITIH1, IGHEP1: Inter-alpha-trypsin inhibitor heavy chain H1 precursor |
1.22 |
Evidence |
|
AVPR2 |
AVPR2, ADHR, DIR, DIR3, V2R: Vasopressin V2 receptor |
CCL14 |
CCL14, NCC2, SCYA14: Small-inducible cytokine A14 precursor |
1.22 |
Evidence |
|
CP |
CP: Ceruloplasmin precursor |
PROC |
PROC: Vitamin K-dependent protein C precursor |
1.22 |
Evidence |
O
|
IL3 |
IL3: Interleukin-3 precursor |
IL12B |
IL12B, NKSF2: Interleukin-12 subunit beta precursor |
1.22 |
Evidence |
|
F9 |
F9: Coagulation factor IX precursor |
CD14 |
CD14: Monocyte differentiation antigen CD14 precursor |
1.22 |
Evidence |
|
ADPRT |
PARP1, ADPRT, PPOL: Poly [ADP-ribose] polymerase 1 |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
1.22 |
Evidence |
|
SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
PROZ |
PROZ: Vitamin K-dependent protein Z precursor |
1.22 |
Evidence |
|
IGF2R |
IGF2R, MPRI: Cation-independent mannose-6-phosphate receptor precursor |
AP2B1 |
AP2B1: Uncharacterized protein AP2B1 |
1.22 |
Evidence |
|
SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
PROZ |
PROZ: Vitamin K-dependent protein Z precursor |
1.22 |
Evidence |
|
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
DCTN1 |
DCTN1: Dynactin subunit 1 |
1.217 |
Evidence |
|
PDLIM5 |
PDLIM5, ENH: PDZ and LIM domain protein 5 |
RAB1B |
RAB1B: Ras-related protein Rab-1B |
1.217 |
Evidence |
|
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
COPS5 |
COPS5, CSN5, JAB1: COP9 signalosome complex subunit 5 |
1.215 |
Evidence |
|
HMGB3 |
HMGB3, HMG2A, HMG4: High mobility group protein B3 |
PLG |
PLG: Plasminogen precursor |
1.215 |
Evidence |
|
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
ZA20D1 |
OTUD7B, ZA20D1: OTU domain-containing protein 7B |
1.21 |
Evidence |
|
ACVR1B |
ACVR1B, ACVRLK4: Activin receptor type-1B precursor |
TOB1 |
TOB1, TOB, TROB1: Protein Tob1 |
1.21 |
Evidence |
|